Herbalife Multivitamin (2019-11-20)

Starting date:
November 20, 2019
Type of communication:
Drug Recall
Subcategory:
Natural health products
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-71774

Last updated:

Summary

  • Product: Herbalife Multivitamin Tablets

Reason

The affected lots do not have childproof packaging. No mention on the label indicating that at least one child-resistant packaging format is available for this product.

Alternate Brand Names: F2 Multivitamin; Multivitamin

Depth of distribution

End users

Affected products

Herbalife Multivitamin Tablets

DIN, NPN, DIN-HIM

NPN 80085527

Dosage form

Tablets

Strength

4-(1,3;1,4)-beta-D-Glucan 4-glucanohydrolase 0.75 FCC CU; 4-alpha-D-Glucan glucanohydrolase 5.5 FCC DU; Beta-carotene 900.0 mcg; Biotin 100.0 mcg; Calcium 146.0 mg; Chromium 33.0 mcg; Copper 0.5 mg; Folate 129.0 mcg; Inositol 2.0 mg; Iodine 46.0 mcg; Iron 2.0 mg; Lycopene 0.36 mg; Magnesium 66.7 mg; Manganese 1.6 mg; Niacinamide 33.3 mg; Potassium 10.0 mg; Protease 81.0 FCC HUT; Riboflavin 8.3 mg; Selenium 17.0 mcg; Thiamine 6.7 mg; Triacylglycerol lipase 2.2 FIP Lipase Units; Vanadium 2.0 mcg; Vitamin B12 1.0 mcg; Vitamin B6 10.0 mg; Vitamin C 43.0 mg; Vitamin D 2.65 mcg; Vitamin E 4.5 mg AT; Zinc 5.0 mg

Lot or serial number

229550A08, 229550B08

Companies

Recalling Firm
Herbalife of Canada Ltd.
113-7075 Place Robert Joncas
Saint-Laurent
H4M 2Z2
Quebec
CANADA
Marketing Authorization Holder
Herbalife International Luxembourg S.á R.L.
990 West 190th Street, Suite 650
Torrance
90502-1014
California
UNITED STATES